Long-term effects of a group support program and an individual support program for informal caregivers of stroke patients: which caregivers benefit the most?

2002 ◽  
Vol 47 (4) ◽  
pp. 291-299 ◽  
Author(s):  
Elisabeth T.P van den Heuvel ◽  
Luc P.de Witte ◽  
Roy E Stewart ◽  
Lidwien M Schure ◽  
Robbert Sanderman ◽  
...  
2000 ◽  
Vol 40 (2) ◽  
pp. 109-120 ◽  
Author(s):  
Elisabeth T.P. van den Heuvel, ◽  
Luc P. de Witte ◽  
Ingrid Nooyen-Haazen ◽  
Robbert Sanderman ◽  
Betty Meyboom-de Jong

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ting-Ann Wang ◽  
Tzy-Haw Wu ◽  
Shin-Liang Pan ◽  
Hsiu-Hsi Chen ◽  
Sherry Yueh-Hsia Chiu

AbstractAspirin and nicametate are well-established therapies for preventing recurrence and mortality from stroke in patients diagnosed as ischemic stroke. However, their respective effects on the recurrence, making allowance for the duration of recurrence and death without the occurrence of recurrence, and long-term survival have not been well elucidated. We aimed to evaluate long-term effect of two kinds of treatment on cerebrovascular death among ischemic stroke patients with or without the recurrence of stroke. Data used in this study were derived from the cohort based on a multicenter randomized double-blind controlled trial during 1992 to 1995 with the enrollment of a total of 466 patients with first-time non-cardioembolic ischemic stroke who were randomly allocated to receive aspirin (n = 222) or nicametate (n = 244). The trial cohort was followed up over time to ascertain the date of recurrence within trial period and death until Sep of 2019. The time-dependent Cox regression model was used to estimate the long-term effects of two treatments on death from cerebrovascular disease with and without recurrence. A total of 49 patients experienced stroke recurrence and 89 cerebrovascular deaths was confirmed. Patients treated with nicametate were more likely, but non statistically significantly, to have recurrence (aHR: 1.73, 95% CI 0.96–3.13) as compared with those treated by aspirin. Nicametate reduced the risk of cerebrovascular death about 37% (aHR: 0.63, 95% CI 0.41–0.97) compared with aspirin. The aspirin group had a lower recurrence rate than the nicametate group even with recurrence after 1–2 years of follow-up of first stroke but the latter had significantly reduced death from cerebrovascular disease for nicametate group, which requires more research to verify.


Medicine ◽  
2018 ◽  
Vol 97 (35) ◽  
pp. e12078 ◽  
Author(s):  
Yu-Chi Huang ◽  
Chau-Peng Leong ◽  
Hui-Hsin Tso ◽  
Mei-Ju Chen ◽  
Mei-Yun Liaw ◽  
...  

Healthcare ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. 175
Author(s):  
Cesar Leal-Costa ◽  
Antonio Lopez-Villegas ◽  
Daniel Catalan-Matamoros ◽  
Emilio Robles-Musso ◽  
Knut Tore Lappegård ◽  
...  

The impact of informal care immediately after pacemaker (PM) implantation has been well established; however, not much is known about its long-term effects. The present study compared personal characteristics, associated problems, workloads, time, and costs related to informal care provided to patients with PM under remote monitoring (RM) vs. conventional monitoring (CM) in the hospital, five years after implantation. The PONIENTE study was a controlled, non-randomized or masked clinical trial conducted with information obtained from the perspective of informal caregivers. Data were collected at 12 and 60 months after PM implantation. The patients in the study were assigned to two different groups: remote monitoring (RM) and conventional monitoring (CM). The “Disability, personal autonomy, and dependency situations survey” (EDAD) was administered to collect information on sociodemographic characteristics, time, care difficulties, health status, professional aspects, and impact on economic, family, or leisure aspects of the main caregivers providing care to patients with pacemakers. After five years, 55 patients completed the study (RM = 21; CM = 34). The average age was 63.14 years (SD = 14.90), 96% of them were women, and the most predominant marital status was married (72%). Informal caregivers lived in the homes of the patients in 70% of cases, and 88% indicated that they had to provide care six to seven days a week. The average cost per patient during the monitoring period studied was 13.17% lower in the RM group than in the CM group, and these differences were not statistically significant (p = 0.35). This study found similar results in the two groups under study with respect to sociodemographic characteristics, workload, time, and problems associated with health, leisure and family members. The costs associated with care were higher in the CM group; however, these differences were not statistically significant.


1991 ◽  
Vol 72 (11) ◽  
pp. 869-873 ◽  
Author(s):  
Gary N Davidoff ◽  
Ofer Keren ◽  
Haim Ring ◽  
Pablo Solzi

2009 ◽  
Vol 23 (7) ◽  
pp. 706-716 ◽  
Author(s):  
Thomas Platz ◽  
Stefanie van Kaick ◽  
Jan Mehrholz ◽  
Ottmar Leidner ◽  
Christel Eickhof ◽  
...  

Background. The study investigated whether passive splinting or active motor training as either individualized best conventional therapy or as standardized impairment-oriented training (IOT) would be superior in promoting motor recovery in subacute stroke patients with mildly or severely paretic arms. Methods. A total of 148 anterior circulation ischemic stroke patients were randomly assigned to 45 minutes of additional daily arm therapy over 3 to 4 weeks as either ( a) passive therapy with inflatable splints or active arm motor therapy as either ( b) individualized best conventional therapy (CONV) or ( c) standardized IOT, that is Arm BASIS training for severe paresis or Arm Ability training for mild paresis. Main outcome measures included the following: Fugl-Meyer arm motor score (severely paretic arms) and the TEMPA time scores (mildly affected arms). Pre—post (immediate effects) and pre—4 weeks follow-up analyses (long-term effects) were performed. Results. Overall improvements were documented (mean baseline and change scores efficacy: Fugl-Meyer, arm motor scores, 24.4, +9.1 points; TEMPA, 119, −26.6 seconds; P < .0001), but with no differential effects between splint therapy and the combined active motor rehabilitation groups. Both efficacy and effectiveness analyses indicated, however, bigger immediate motor improvements after IOT as compared with best conventional therapy (Fugl-Meyer, arm motor scores: IOT +12.3, CONV +9.2 points; TEMPA: IOT −31.1 seconds, CONV −20.5 seconds; P = .0363); for mildly affected patients long-term effects could also be substantiated. Conclusions. Specificity of active training seemed more important for motor recovery than intensity (therapy time). The comprehensive modular IOT approach promoted motor recovery in patients with either severe or mild arm paresis.


PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e113766
Author(s):  
Hideki Sugimoto ◽  
Shingo Konno ◽  
Nobuatsu Nomoto ◽  
Hiroshi Nakazora ◽  
Mayumi Murata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document